epigallocatechin gallate has been researched along with imatinib mesylate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chi, HT; Hara, Y; Iwasaki, R; Sato, Y; Taguchi, T; Thao, le B; Vu, HA; Watanabe, T | 1 |
| Adams, E; Chen, H; Van Schepdael, A | 1 |
2 other study(ies) available for epigallocatechin gallate and imatinib mesylate
| Article | Year |
|---|---|
Green tea (-)-epigalocatechin-3-gallate inhibits KIT activity and causes caspase-dependent cell death in gastrointestinal stromal tumor including imatinib-resistant cells.
Topics: Animals; Apoptosis; Benzamides; Blotting, Western; Caspase 3; Caspase 8; Caspase 9; Caspases; Catechin; Cell Line; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Tea; Time Factors | 2009 |
Study of Abl1 tyrosine kinase inhibitors by liquid chromatography-electrospray ionization-mass spectrometry.
Topics: Amino Acid Sequence; Benzamides; Biological Products; Caffeic Acids; Catechin; Chromatography, Liquid; Drug Discovery; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Limit of Detection; Peptides; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Spectrometry, Mass, Electrospray Ionization | 2013 |